Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
Nonalcoholic Fatty Liver Disease: Pathophysiology and Management.
复制标题
DOI:
10.1016/j.gtc.2016.07.003
复制
发表时间:
2016-12
影响因子:
3.7
通讯作者:
Khungar V
中科院分区:
文献类型:
--
作者:
Carr RM;Oranu A;Khungar V
NAFLD is an important cause of morbidity and mortality worldwide both because of cardiovascular, hepatic and oncologic sequelae as well as because it is rapidly becoming the leading cause of end stage liver disease and liver transplant. With a prevalence of 30% in the US, it has reached epidemic proportions. While the metabolic syndrome is a common risk factor, there are differences among racial and ethnic groups, suggesting the complex interaction between hormonal, nutritional and genetic factors at play in disease pathogenesis. The clinical syndrome of NAFLD spans from bland steatosis to steatohepatitis which can progress to fibrosis and cirrhosis. The pathogenesis including roles of hormones, nutritional and intestinal dysbiosis, insulin resistance, lipotoxicity, and hepatic inflammation, and genes are examined. Non-invasive testing and liver biopsy indications are reviewed. Approved and investigational therapies for NAFLD and NASH are outlined in this review of a disease that is currently an area of great interest to the hepatology community.
登录
查看更多内容
影响因子:
13.5
作者:
Feldstein, Ariel E.;Wieckowska, Anna;Lopez, A. Rocio;Liu, Yao-Chang;Zein, Nizar N.;McCullough, Arthur J.
通讯作者:
McCullough, Arthur J.
影响因子:
4.3
作者:
Fleischman, Michael Wayne;Budoff, Matthew;Foster, Temitope
通讯作者:
Foster, Temitope
影响因子:
7.7
作者:
Abu Dayyeh, Barham K.;Edmundowicz, Steven A.;Banerjee, Subhas
通讯作者:
Banerjee, Subhas
影响因子:
13.5
作者:
Browning, JD;Szczepaniak, LS;Hobbs, HH
通讯作者:
Hobbs, HH
影响因子:
29.4
作者:
Gao B;Tsukamoto H
通讯作者:
Tsukamoto H